Tarsus Pharmaceuticals
The Medical Science Liaison (MSL) at Tarsus will engage optometrists and ophthalmologists across a multi‑state territory, providing compliant scientific exchange, whole‑practice education, and support for clinical trials and medical information. This field‑based role requires extensive travel, KOL relationship management, and the collection of insights to shape medical strategy.
Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with high unmet need, with a primary focus on eye care. The company markets XDEMVY® (lotilaner ophthalmic solution) 0.25%, the first and only FDA-approved treatment for Demodex blepharitis, and has a pipeline targeting conditions such as ocular rosacea and Lyme disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tarsus Pharmaceuticals.
50% above the average for this role
Medical Science Liaison/Senior Medical Science Liaison
EVERSANA
Medical Science Liaison
Kardigan
Medical Science Liaison/Senior Medical Science Liaison
EVERSANA
Medical Science Liaison/Senior Medical Science Liaison
EVERSANA
Medical Science Liaison/Senior Medical Science Liaison - Ophthalmology - Central
EVERSANA
Medical Science Liaison/Senior Medical Science Liaison - Ophthalmology - Southeast
EVERSANA